FDA Raises Concerns About Fibromyalgia Drug - MashGet
Links shared publicly online about this topic.
- 938total visits
FDA Raises Concerns About Fibromyalgia Drug - MashGet
View full resource at mashget.com
Tags: Fibromyalgia, Fibromyalgia Medication, Drug, Pharma, FDA
Most Recently Shared on August 18, 2010 at 6:15 pm By:
RT @mg_health: FDA Raises Concerns About Fibromyalgia Drug via @WSJ... http://bit.ly/cRHzWt
FDA Warns on Statins - WSJ.com
online.wsj.com — “The Food and Drug Administration is raising safety concerns about the popular class of cholesterol-fighting drugs called statins, warning that patients taking the drugs may face a small increased risk of higher blood sugar levels and of being diagnosed with diabetes.” View full resource at online.wsj.com
Most Recently Shared on February 28, 2012 at 6:09 pm By:
Scott Strumello Patient Expert
http://t.co/Ld8D5lbR: FDA Warns on Statins http://t.co/ylkWdM4H
World Poultry - News: US poultry orgs raise concerns about roxarsone ban
worldpoultry.net — “US poultry organisations, US Poultry & Egg Association and the National Chicken Council, have written to the FDA to share concerns about the recent suspension of the sale of roxarsone animal drug products.” View full resource at worldpoultry.net
Most Recently Shared on September 6, 2011 at 2:53 pm By:
Dr Kelly Sennholz Emergency Physician, Physician, Doctor, and Internist
Corporate poultry orgs fight removal of carcinogen arsenic from poultry feed: http://t.co/FJvkFwE It makes meat pink, found in meat tissue
Hepatitis C Drugs Await FDA Approval - FoxNews.com
foxnews.com — “A Food and Drug Administration (FDA) staff review of Merck & Co.'s proposed hepatitis C drug boceprevir has raised safety concerns about anemia and other blood disorders” View full resource at foxnews.com
Most Recently Shared on April 27, 2011 at 10:55 pm By:
Health,Fitness,Diet Health Business
Hepatitis C Drugs Await FDA Approval http://bit.ly/kTLZHV
Hepatitis C Drugs Await FDA Approval - WSJ.com
online.wsj.com — “An FDA staff review of Merck's proposed hepatitis C drug boceprevir found the drug to be effective, but raised safety concerns about anemia and other blood disorders.” View full resource at online.wsj.com
Most Recently Shared on April 25, 2011 at 2:58 pm By:
Panel Raises Concerns About Hepatitis Drug http://on.wsj.com/hVEz3l
Issues seen with drugs to curb prostate cancer: FDA
health.yahoo.net — “U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.” View full resource at health.yahoo.net
Most Recently Shared on November 29, 2010 at 6:40 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Issues seen with drugs to curb prostate cancer: FDA: U.S. regulatory staff have raised concerns about data for t... http://bit.ly/fh5C9B
Issues seen with drugs to curb prostate cancer: FDA
health.yahoo.net — “U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.” View full resource at health.yahoo.net
Most Recently Shared on November 29, 2010 at 6:27 pm By:
Jane Anderson Healthy Eating Advisor
Issues seen with drugs to curb prostate cancer: FDA http://bit.ly/hnceAQ
Issues seen with drugs to curb prostate cancer: FDA | Reuters
reuters.com — “WASHINGTON (Reuters) - U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain” View full resource at reuters.com
Most Recently Shared on November 29, 2010 at 6:23 pm By:
Hisham Rana, MD Doctor and Physician
News: Issues seen with drugs (Avodart and Proscar) to curb prostate cancer: FDA http://reut.rs/fSpS8f - #health #pharma
FDA Raises Concerns - WSJ.com
online.wsj.com — “The FDA raised safety concerns about a proposed Jazz Pharmaceuticals drug to treat the pain disorder fibromyalgia, including the potential for misuse and abuse of the product.” View full resource at online.wsj.com
Most Recently Shared on August 18, 2010 at 6:17 pm By:
FDA Raises Concerns About Fibromyalgia Drug http://on.wsj.com/alFRVG
FDA Eyes Jazz Pharmaceuticals Fibromyalgia Drug - ABC News
abcnews.go.com — “FDA Eyes Jazz Pharmaceuticals Fibromyalgia Drug” View full resource at abcnews.go.com
Most Recently Shared on August 18, 2010 at 5:05 pm By:
FDA Eyes Jazz Pharmaceuticals Fibromyalgia Drug: FDA has concerns about misuse of Jazz Pharmaceuticals drug if cle... http://bit.ly/aPJW2B
FOXBusiness.com - FDA Raises Safety Concerns About Proposed Jazz Fibromyalgia Drug
foxbusiness.com — “FOXBusiness.com - FDA Raises Safety Concerns About Proposed Jazz Fibromyalgia Drug” View full resource at foxbusiness.com
Most Recently Shared on August 18, 2010 at 5:05 pm By:
FDA Raises Safety Concerns About Proposed Jazz Fibromyalgia Drug: FDA Raises Safety Concerns About Proposed Jazz F... http://bit.ly/cre7eH
FDA Avandia Panel Member Found to Have Received Fees from Drug Maker - AboutLawsuits.com
aboutlawsuits.com — “Concerns have been raised that a member of the FDA Advisory Panel that recently voted that the diabetes drug Avandia should not be recalled may have failed to” View full resource at aboutlawsuits.com
Most Recently Shared on July 20, 2010 at 6:44 pm By:
FDA Avandia Panel Member Found to Have Received Fees from Drug Maker - AboutLawsuits.com http://ow.ly/18dmMM
Diabetes drug Avandia has FDA split over new concerns about its safety
washingtonpost.com — “New federal analyses released Friday raised additional questions about the safety of the controversial diabetes drug Avandia.” View full resource at washingtonpost.com
Most Recently Shared on July 12, 2010 at 2:05 pm By:
#Avandia comes under the bright lights this week at #FDA http://bit.ly/afIrFJ
Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request
news-medical.net — “Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.” View full resource at news-medical.net
Most Recently Shared on June 22, 2010 at 6:23 am By:
Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request: Pfizer Inc. today announ... http://bit.ly/ddq9Uc
FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market
fda.gov — “Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.” View full resource at fda.gov
Most Recently Shared on June 21, 2010 at 7:34 pm By:
NCI Cancer Bulletin Health News
FDA: Pfizer Voluntarily withdraws the cancer treatment Mylotarg (gemtuzumab ozogamicin) from the U.S. Market. http://j.mp/9k2g89
The FDA Questions Safety of Boehringer Ingelheim's Flibanserin, a 'Female Viagra' - WSJ.com
online.wsj.com — “Regulators raised concerns about the proposed drug's effectiveness as a treatment for low-sex drive and about how safe it would be if used widely.” View full resource at online.wsj.com
Most Recently Shared on June 17, 2010 at 2:31 am By:
FDA Questions Safety of 'Female Viagra' http://on.wsj.com/bqQvXg
Advertisement
